Literature DB >> 15063760

Activity of the isolated HIV RNase H domain and specific inhibition by N-hydroxyimides.

Julie Qi Hang1, Surendran Rajendran, Yanli Yang, Yu Li, Philippe Wong Kai In, Hilary Overton, Kevin E B Parkes, Nick Cammack, Joseph A Martin, Klaus Klumpp.   

Abstract

This report describes a procedure to generate enzymatically active, isolated HIV RNase H domain. In contrast to previously described preparations, the RNA cleavage activity of the untagged RNase H domain was surprisingly similar to that of the full-length HIV-RT protein. Signature cleavages at 18 and 9 nucleotides downstream of a recessed RNA 5'-end were retained with the isolated RNase H domain. Activity was strongly decreased by deletion of 3 amino acids from the C-terminus, consistent with an important structural or functional role of the C-terminal alpha-helix. A prototype N-hydroxyimide (2-hydroxy-4H-isoquinoline-1,3-dione) was found to inhibit the activity of the isolated HIV RNase H domain as well as the RNase H activity of full-length HIV reverse transcriptase. In contrast, the compound did not significantly inhibit the structurally closely related Escherichia coli RNase HI. Specific binding of N-hydroxyimide compounds to the isolated RNase H domain was observed by protein fluorescence quenching.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15063760     DOI: 10.1016/j.bbrc.2004.03.061

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  22 in total

1.  Sequence, distance, and accessibility are determinants of 5'-end-directed cleavages by retroviral RNases H.

Authors:  Sharon J Schultz; Miaohua Zhang; James J Champoux
Journal:  J Biol Chem       Date:  2005-11-22       Impact factor: 5.157

2.  Hepatitis B virus replication is blocked by a 2-hydroxyisoquinoline-1,3(2H,4H)-dione (HID) inhibitor of the viral ribonuclease H activity.

Authors:  Catherine W Cai; Elena Lomonosova; Eileen A Moran; Xiaohong Cheng; Kunjan B Patel; Fabrice Bailly; Philippe Cotelle; Marvin J Meyers; John E Tavis
Journal:  Antiviral Res       Date:  2014-05-20       Impact factor: 5.970

Review 3.  Novel approaches to inhibiting HIV-1 replication.

Authors:  Catherine S Adamson; Eric O Freed
Journal:  Antiviral Res       Date:  2009-09-24       Impact factor: 5.970

4.  Expression of an Mg2+-dependent HIV-1 RNase H construct for drug screening.

Authors:  Richard V Farias; Deborah A Vargas; Andres E Castillo; Beatriz Valenzuela; Marie L Coté; Monica J Roth; Oscar Leon
Journal:  Antimicrob Agents Chemother       Date:  2011-07-18       Impact factor: 5.191

Review 5.  Targeting Metalloenzymes for Therapeutic Intervention.

Authors:  Allie Y Chen; Rebecca N Adamek; Benjamin L Dick; Cy V Credille; Christine N Morrison; Seth M Cohen
Journal:  Chem Rev       Date:  2018-09-07       Impact factor: 60.622

6.  Crystal structure of the moloney murine leukemia virus RNase H domain.

Authors:  David Lim; G Glenn Gregorio; Craig Bingman; Erik Martinez-Hackert; Wayne A Hendrickson; Stephen P Goff
Journal:  J Virol       Date:  2006-09       Impact factor: 5.103

7.  Alizarine derivatives as new dual inhibitors of the HIV-1 reverse transcriptase-associated DNA polymerase and RNase H activities effective also on the RNase H activity of non-nucleoside resistant reverse transcriptases.

Authors:  Francesca Esposito; Tatyana Kharlamova; Simona Distinto; Luca Zinzula; Yung-Chi Cheng; Ginger Dutschman; Giovanni Floris; Patrick Markt; Angela Corona; Enzo Tramontano
Journal:  FEBS J       Date:  2011-03-16       Impact factor: 5.542

8.  Identification of alternative binding sites for inhibitors of HIV-1 ribonuclease H through comparative analysis of virtual enrichment studies.

Authors:  Anthony K Felts; Krystal Labarge; Joseph D Bauman; Dishaben V Patel; Daniel M Himmel; Eddy Arnold; Michael A Parniak; Ronald M Levy
Journal:  J Chem Inf Model       Date:  2011-07-26       Impact factor: 4.956

9.  Structure of HIV-1 reverse transcriptase with the inhibitor beta-Thujaplicinol bound at the RNase H active site.

Authors:  Daniel M Himmel; Karen A Maegley; Tom A Pauly; Joseph D Bauman; Kalyan Das; Chhaya Dharia; Arthur D Clark; Kevin Ryan; Michael J Hickey; Robert A Love; Stephen H Hughes; Simon Bergqvist; Eddy Arnold
Journal:  Structure       Date:  2009-12-09       Impact factor: 5.006

10.  HIV-1 reverse transcriptase can simultaneously engage its DNA/RNA substrate at both DNA polymerase and RNase H active sites: implications for RNase H inhibition.

Authors:  Greg L Beilhartz; Michaela Wendeler; Noel Baichoo; Jason Rausch; Stuart Le Grice; Matthias Götte
Journal:  J Mol Biol       Date:  2009-03-13       Impact factor: 5.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.